Comparison between Cian Healthcare IPO and Par Drugs IPO.
Cian Healthcare IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.
| Cian Healthcare IPO | Par Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Fedex Securities Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Cian Healthcare IPO is up to ₹35.99 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Cian Healthcare IPO is ₹61.00 per share and of Par Drugs IPO is ₹51.00 per share.
| Cian Healthcare IPO | Par Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹59.00 per share | |
| Issue Price (Upper) | ₹65.00 per share | |
| Issue Price (Final) | ₹61.00 per share | ₹51.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 59,00,000 shares | 15,88,000 shares |
| Fresh Issue Size (Amount) | up to ₹35.99 Cr | up to ₹8.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 59,00,000 shares | 15,88,000 shares |
| Issue Size Total (Amount) | up to ₹35.99 Cr | up to ₹8.10 Cr |
Cian Healthcare IPO opens on May 02, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Cian Healthcare IPO and Par Drugs IPO is May 15, 2019, and May 08, 2019, respectively.
| Cian Healthcare IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 02, 2019 | May 03, 2019 |
| Issue Close | May 15, 2019 | May 08, 2019 |
| Basis Of Allotment (Tentative) | May 20, 2019 | May 13, 2019 |
| Initiation of Refunds (Tentative) | May 21, 2019 | May 14, 2019 |
| Credit of Share (Tentative) | May 22, 2019 | May 15, 2019 |
| Listing date (Tentative) | May 23, 2019 | May 16, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cian Healthcare IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .
| Cian Healthcare IPO | Par Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 96.60 | 99.55 | ||||
| Promoter Shareholding (Post-Issue) | 72.82 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹142.50 Cr. | ₹31.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Cian Healthcare IPO Retail Individual Investors (RII) are offered 29,50,000 shares while in Par Drugs IPO retail investors are offered 29,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Cian Healthcare IPO and in Par Drugs IPO.
| Cian Healthcare IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 3,16,000 shares | 84,000 shares |
| QIB | ||
| NII | 29,50,000 shares | 7,78,000 shares |
| RII | 29,50,000 shares | 7,80,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 59,00,000 shares | 15,88,000 shares |
Cian Healthcare IPO subscribed 1.25x in total, whereas Par Drugs IPO subscribed 5.64x.
| Cian Healthcare IPO | Par Drugs IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.91x | 3.48x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.59x | 7.97x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 1.25x | 5.64x |
